You are here: Home » PTI Stories » National » News
Business Standard

Two doctors from AIIMS win BMJ Awards South Asia

Press Trust of India  |  New Delhi 

Two doctors from AIIMS today won the BMJ Awards South Asia in separate categories for strengthening drug de-addiction programme and for intermittent supervised therapy for abdominal tuberculosis.

Atul Ambekar (Psychiatry) bagged the award under the category of 'Non-communicable Disease Initiative of the Year' for strengthening drug de-addiction programme and Govind Makharia (Gastroenterology) won the award for intermittent supervised therapy for abdominal tuberculosis under the 'Research Paper of the Year' category.

BMJ (British Medical Journal), one of the world's leading medical journals, recognises individuals and teams who have worked tirelessly to champion the cause of healthcare in South Asia.

Marie Gilbert Majella from JIPMER Pondicherry was awarded under the 'PG Thesis Paper of the Year' category for her thesis on tuberculosis which continues to be a major cause of mortality in developing countries.

Besides, Manisha Acharya from Dr Shroff's Charity Eye Hospital got the award in the category of 'Quality Improvement Team of the Year' for improvement in eye bank tissue utilisation through quality assurance initiatives.

The awards, considered the 'Academy Awards' of the medical field, were given in 10 categories, selected from more than 1500 high-quality nominations by a panel of eminent medical professionals.

Prashant Mishra, Managing Director, BMJ India said, "Our vision is to create a healthier world and we consistently create opportunities and platforms that can bring important stakeholders together in healthcare. The Healthcare Summit and Awards reflect our desire to highlight cases of South Asian clinical excellence and raise questions that determine the further of healthcare.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, November 19 2016. 22:57 IST
RECOMMENDED FOR YOU